Treatment of anal fistulas with Obsidian RFT
Anal fistula
Minimal invasive surgery
Obsidian
Platelet-rich fibrin foam
Journal
Techniques in coloproctology
ISSN: 1128-045X
Titre abrégé: Tech Coloproctol
Pays: Italy
ID NLM: 9613614
Informations de publication
Date de publication:
02 Aug 2024
02 Aug 2024
Historique:
received:
15
03
2024
accepted:
22
06
2024
medline:
3
8
2024
pubmed:
3
8
2024
entrez:
2
8
2024
Statut:
epublish
Résumé
Sphincter-preserving techniques like autologous compound platelet-rich fibrin foam have gained popularity, offering potential for better functional outcomes in anal fistula treatment. The present study aimed to evaluate the efficacy and safety of Obsidian RFT The study conducted a retrospective analysis from January 2018 to December 2022 on patients who received anal fistula closure with Obsidian RTF Fifteen patients received Obsidian RFT® treatment for anal fistulas. We found no intra- and postoperative complications. The median hospital stay was 3 days. After a median follow-up of 32 months, a closure rate of 53.3% was detected. Non-significant differences were observed in various variables, yet trends emerged, indicating associations between abscess presence and non-healing fistulas. A distinct age threshold (≥ 42.7 years) served as an indicator for an inability to achieve anal fistula cure. Obsidian RFT Ethical Approval number Medical University of Vienna (#1258/2018). This study was registered retrospectively in ClinicalTrials.gov (NCT06136325).
Sections du résumé
BACKGROUND
BACKGROUND
Sphincter-preserving techniques like autologous compound platelet-rich fibrin foam have gained popularity, offering potential for better functional outcomes in anal fistula treatment. The present study aimed to evaluate the efficacy and safety of Obsidian RFT
METHODS
METHODS
The study conducted a retrospective analysis from January 2018 to December 2022 on patients who received anal fistula closure with Obsidian RTF
RESULTS
RESULTS
Fifteen patients received Obsidian RFT® treatment for anal fistulas. We found no intra- and postoperative complications. The median hospital stay was 3 days. After a median follow-up of 32 months, a closure rate of 53.3% was detected. Non-significant differences were observed in various variables, yet trends emerged, indicating associations between abscess presence and non-healing fistulas. A distinct age threshold (≥ 42.7 years) served as an indicator for an inability to achieve anal fistula cure.
CONCLUSION
CONCLUSIONS
Obsidian RFT
TRIAL REGISTRATION
BACKGROUND
Ethical Approval number Medical University of Vienna (#1258/2018). This study was registered retrospectively in ClinicalTrials.gov (NCT06136325).
Identifiants
pubmed: 39095560
doi: 10.1007/s10151-024-02968-6
pii: 10.1007/s10151-024-02968-6
doi:
Banques de données
ClinicalTrials.gov
['NCT06136325']
Types de publication
Journal Article
Evaluation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
93Informations de copyright
© 2024. The Author(s).
Références
Schwartz DA, Wiersema MJ, Dudiak KM, Fletcher JG, Clain JE, Tremaine WJ et al (2001) A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn’s perianal fistulas. Gastroenterology 121(5):1064–1072
doi: 10.1053/gast.2001.28676
pubmed: 11677197
Sonoda T, Hull T, Piedmonte MR, Fazio VW (2002) Outcomes of primary repair of anorectal and rectovaginal fistulas using the endorectal advancement flap. Dis Colon Rectum 45(12):1622–1628
doi: 10.1007/s10350-004-7249-y
pubmed: 12473885
Sainio P (1984) Fistula-in-ano in a defined population: incidence and epidemiological aspects. Ann Chir Gynaecol 73(4):219–224
pubmed: 6508203
Garg PK, Jain BK (2011) Seton drainage in high anal fistula. Int J Colorectal Dis 26(11):1495
doi: 10.1007/s00384-011-1144-5
pubmed: 21279366
Lara FJ, Serrano AM, Moreno JU, Carmona JH, Marquez MF, Perez LR et al (2015) Platelet-rich fibrin sealant as a treatment for complex perianal fistulas: a multicentre study. J Gastrointest Surg 19(2):360–368
doi: 10.1007/s11605-014-2698-7
pubmed: 25421358
Vidon M, Munoz-Bongrand N, Lambert J, Maggiori L, Zeitoun JD, Corte H et al (2021) Long-term efficacy of fibrin glue injection for perianal fistulas in patients with Crohn’s disease. Colorectal Dis 23(4):894–900
doi: 10.1111/codi.15477
pubmed: 33278859
Garcia-Olmo D, Gomez-Barrera M, de la Portilla F (2023) Surgical management of complex perianal fistula revisited in a systematic review: a critical view of available scientific evidence. BMC Surg 23(1):29
doi: 10.1186/s12893-023-01912-z
pubmed: 36740680
pmcid: 9901165
Alio JL, Rodriguez AE, Martinez LM, Rio AL (2013) Autologous fibrin membrane combined with solid platelet-rich plasma in the management of perforated corneal ulcers: a pilot study. JAMA Ophthalmol 131(6):745–751
doi: 10.1001/jamaophthalmol.2013.2474
pubmed: 23559361
Eppley BL, Pietrzak WS, Blanton M (2006) Platelet-rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg 118(6):147e-e159
doi: 10.1097/01.prs.0000239606.92676.cf
pubmed: 17051095
Eppley BL, Woodell JE, Higgins J (2004) Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg 114(6):1502–1508
doi: 10.1097/01.PRS.0000138251.07040.51
pubmed: 15509939
Li Q, Pan S, Dangaria SJ, Gopinathan G, Kolokythas A, Chu S et al (2013) Platelet-rich fibrin promotes periodontal regeneration and enhances alveolar bone augmentation. Biomed Res Int 2013:638043
pubmed: 23586051
pmcid: 3622372
Liao HT, Chen CT, Chen CH, Chen JP, Tsai JC (2011) Combination of guided osteogenesis with autologous platelet-rich fibrin glue and mesenchymal stem cell for mandibular reconstruction. J Trauma 70(1):228–237
pubmed: 20664370
Singh A, Kohli M, Gupta N (2012) Platelet rich fibrin: a novel approach for osseous regeneration. J Maxillofac Oral Surg 11(4):430–434
doi: 10.1007/s12663-012-0351-0
pubmed: 24293936
pmcid: 3485469
Shamiyeh A, Klugsberger B, Aigner C, Schimetta W, Herbst F, Dauser B (2021) Obsidian ASG(R) autologous platelet-rich fibrin matrix and colorectal anastomotic healing: a preliminary study. Surg Technol Int 39:147–154
doi: 10.52198/21.STI.39.CR11508
pubmed: 34736288
Dauser B, Heitland W, Bader FG, Brunner W, Nir Y, Zbar AP (2020) Histologic changes in early colonic anastomotic healing using autologous platelet-rich fibrin matrix. Eur Surg 52(4):155–164
doi: 10.1007/s10353-019-0578-9
Parks AG, Gordon PH, Hardcastle JD (1976) A classification of fistula-in-ano. Br J Surg 63(1):1–12
doi: 10.1002/bjs.1800630102
pubmed: 1267867
Dodd RA, Cornwell R, Holm NE, Garbarsch A, Hollingsbee DA (2002) The Vivostat application system: a comparison with conventional fibrin sealant application systems. Technol Health Care 10(5):401–411
doi: 10.3233/THC-2002-10504
pubmed: 12368560
van der Hagen SJ, Baeten CG, Soeters PB, Beets-Tan RG, Russel MG, van Gemert WG (2005) Staged mucosal advancement flap for the treatment of complex anal fistulas: pretreatment with noncutting Setons and in case of recurrent multiple abscesses a diverting stoma. Colorectal Dis 7(5):513–518
doi: 10.1111/j.1463-1318.2005.00850.x
pubmed: 16108891
Nasseri Y, Cassella L, Berns M, Zaghiyan K, Cohen J (2016) The anal fistula plug in Crohn’s disease patients with fistula-in-ano: a systematic review. Colorectal Dis 18(4):351–356
doi: 10.1111/codi.13268
pubmed: 26749385
Dawoud C, Widmann KM, Czipin S, Pramhas M, Scharitzer M, Stift A et al (2023) Efficacy of cx601 (darvadstrocel) for the treatment of perianal fistulizing Crohn’s disease: a prospective nationwide multicenter cohort study. Wien Klin Wochenschr 136(9):289–294
pubmed: 37823920
pmcid: 11078846
Hedelin H, Nilson AE, Teger-Nilsson AC, Thorsen G (1982) Fibrin occlusion of fistulas postoperatively. Surg Gynecol Obstet 154(3):366–368
pubmed: 7064072
Yeung JM, Simpson JA, Tang SW, Armitage NC, Maxwell-Armstrong C (2010) Fibrin glue for the treatment of fistulae in ano–a method worth sticking to? Colorectal Dis 12(4):363–366
doi: 10.1111/j.1463-1318.2009.01801.x
pubmed: 19220380
van Koperen PJ, Wind J, Bemelman WA, Bakx R, Reitsma JB, Slors JF (2008) Long-term functional outcome and risk factors for recurrence after surgical treatment for low and high perianal fistulas of cryptoglandular origin. Dis Colon Rectum 51(10):1475–1481
doi: 10.1007/s10350-008-9354-9
pubmed: 18626715
Adams T, Yang J, Kondylis LA, Kondylis PD (2008) Long-term outlook after successful fibrin glue ablation of cryptoglandular transsphincteric fistula-in-ano. Dis Colon Rectum 51(10):1488–1490
doi: 10.1007/s10350-008-9405-2
pubmed: 18612689
de Parades V, Far HS, Etienney I, Zeitoun JD, Atienza P, Bauer P (2010) Seton drainage and fibrin glue injection for complex anal fistulas. Colorectal Dis 12(5):459–463
doi: 10.1111/j.1463-1318.2009.01811.x
pubmed: 19210300
de la Portilla F, Munoz-Cruzado MVD, Maestre MV, Garcia-Cabrera AM, Reyes ML, Vazquez-Monchul JM et al (2019) Platelet-rich plasma (PRP) versus fibrin glue in cryptogenic fistula-in-ano: a phase III single-center, randomized, double-blind trial. Int J Colorectal Dis 34(6):1113–1119
doi: 10.1007/s00384-019-03290-6
pubmed: 31037566
Abdollahi A, Emadi E, Hamidi AD (2023) Autologous platelet-rich-plasma injection and platelet-rich fibrin glue interposition for treatment of anal fistula resistant to surgery. Gastroenterol Hepatol Bed Bench 16(3):292–296
pubmed: 37767316
pmcid: 10520388
van der Hagen SJ, Baeten CG, Soeters PB, van Gemert WG (2011) Autologous platelet-derived growth factors (platelet-rich plasma) as an adjunct to mucosal advancement flap in high cryptoglandular perianal fistulae: a pilot study. Colorectal Dis 13(2):215–218
doi: 10.1111/j.1463-1318.2009.01991.x
pubmed: 19575739
Perez Lara FJ, Hernandez Gonzalez JM, Prieto-PugaArjona T, Moya Donoso FJ, Doblas FJ (2022) A new, conservative treatment for perianal fistula that may halve the need for surgical intervention: case series. Surg Innov 29(1):50–55
doi: 10.1177/15533506211015196
pubmed: 33904796
Panes J, Garcia-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC et al (2016) Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial. Lancet 388(10051):1281–1290
doi: 10.1016/S0140-6736(16)31203-X
pubmed: 27477896
Kita A, Yamamoto S, Saito Y, Chikenji TS (2024) Cellular senescence and wound healing in aged and diabetic skin. Front Physiol 15:1344116
doi: 10.3389/fphys.2024.1344116
pubmed: 38440347
pmcid: 10909996